PINL:GRPOF - Post by User
Post by
av8tor42on Jan 02, 2018 5:40pm
151 Views
Post# 27265661
Have a look...
Have a look... Tetra Bio-Pharma Inc. Condensed Consolidated Interim Statements of Financial Position (Expressed in Canadian dollars) As at May 31, November 30, 2017 2016 |
| |
| | | |
Current assets
Cash
Accounts receivable (Note 6) Prepaid expenses 2,704,636 291,101 196,589 |
Total current assets 3,192,326 1,372,211 Non-current assets
Intangible assets (Note 7) 536,400 216,000 |
Total assets 3,728,726 1,588,211 |
LIABILITIES Current liabilities
Accounts payable and accrued liabilities 219,890 191,667 |
SHAREHOLDERS' EQUITY Share capital (Note 8) Warrants (Note 9) Contributed surplus Accumulated deficit 7,442,385 407,569 714,193 (4,657,095) 2,511,021 503,195 337,922 (1,902,885) |
Equity attributable to equity holders of the Parent Company 3,907,052 1,449,253 Equity attributable to non controlling interest (Note 11) (398,216) (52,709) |
Total equity 3,508,836 1,396,544 |
Total liabilities and shareholders' equity 3,728,726 1,588,211 |
| |